Skip to main content
MedPathMedPath Home
Clinical Trials/ITMCTR2000003596
ITMCTR2000003596
Not yet recruiting
Phase 1

Traditional Chinese medicine formulation combined with promestriene in the treatment of genitourinary syndrome of menopause (GSM) : a randomized, double-blind, controlled clinical trial

International Peace Maternity & Child Health Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China0 sitesTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsgenitourinary syndrome of menopause, GSM

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
genitourinary syndrome of menopause, GSM
Sponsor
International Peace Maternity & Child Health Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China
Status
Not yet recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Female

Investigators

Sponsor
International Peace Maternity & Child Health Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China

Eligibility Criteria

Inclusion Criteria

  • •1\.2 inclusion criteria
  • •1\.2\.1 the postmenopausal women meeting the GSM diagnostic criteria and age over 40 years old
  • •1\.2\.2 the people of no use of hormonal drugs at least 3 months
  • •1\.2\.3 the people volunteered for the experiment, and signed the informed consent

Exclusion Criteria

  • •1\.3 exclusion standard
  • •1\.3\.1the people without sexual partners because of unmarried, divorced, widowed and other reasons
  • •1\.3\.2 the people who use GnRH \- a or steroid hormone in three months
  • •1\.3\.3 the people who place levonorgestrel intrauterine sustained release system into uterus
  • •1\.3\.4 the people who have severe disease about heart and cerebral vessels or liver or kidney or diabetes or malignant tumor or the others.
  • •1\.3\.5 the people who affect cognition on account of mental disorder or medicine or chronic drinking
  • •1\.3\.6 the people who have coagulation dysfunction or thrombotic disease
  • •1\.3\.7 the people who participate in other drug clinical trials

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
The clinical effect of traditional chinese medicine on middle-aged women with Interstitial Cystitis: protocol for a randomized controlled trial
ITMCTR2000003031The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
Not yet recruiting
Phase 1
Combination of traditional Chinese medicine and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19)
ITMCTR2000002955Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University/Beijing institute of Traditional Chinese MedHubei integrated traditional Chinese and Western Medicine Hospital
Not yet recruiting
Not Applicable
Traditional Chinese medicine combined with conventional therapy for Female kidney stone: a randomized controlled trialFemale kidney stone
ITMCTR2000003017The Second Affiliated Hospital of Shanxi University of Chinese Medicine
Recruiting
Phase 1
Effect of Longmu Gegen Decoction on herpes zoster and its effect on T cell subsetsherpes zoster
ITMCTR2100005123Xiyuan Hospital of CACMS
Not yet recruiting
Phase 1
Study on chronic disease management with traditional Chinese medicine characteristics on remission stage of psoriasis vulgarisPsoriasisL40.900
ITMCTR2200005728Shanxi Hospital of traditional Chinese Medicine